Overview
Ramosetron is a serotonin 5-HT3 receptor antagonist commonly employed to treat nausea and vomiting, in addition to certain diarrheal conditions. It is believed to have higher potency and longer antiemetic action than other 1st generation 5-HT3 antagonists such as ondansetron. Currently, ramosetron is only approved for use Japan and in certain Southeast Asian countries.
Indication
For the treatment of nausea and vomiting and diarrhea-predominant irritable bowel syndrome in males.
Associated Conditions
- Gastrointestinal Symptoms caused by cancer treatment
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/12/12 | Phase 2 | Not yet recruiting | |||
2022/10/13 | Not Applicable | Recruiting | |||
2022/04/13 | Phase 4 | Completed | |||
2020/03/05 | Phase 4 | UNKNOWN | |||
2018/01/24 | Not Applicable | UNKNOWN | |||
2017/09/11 | Phase 4 | Completed | |||
2017/07/27 | Not Applicable | Completed | |||
2017/01/11 | Not Applicable | Completed | |||
2016/08/17 | Early Phase 1 | UNKNOWN | |||
2016/07/29 | Phase 4 | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Ramosetron Hydrochloride Injection | 国药准字H20054553 | 化学药品 | 注射剂 | 5/11/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20056888 | 化学药品 | 注射剂 | 7/23/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20055728 | 化学药品 | 注射剂 | 7/30/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20056187 | 化学药品 | 注射剂 | 5/12/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20064570 | 化学药品 | 注射剂 | 11/11/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20054781 | 化学药品 | 注射剂 | 8/4/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20055202 | 化学药品 | 注射剂 | 9/30/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20064329 | 化学药品 | 注射剂 | 12/14/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20058617 | 化学药品 | 注射剂 | 6/22/2020 | |
| Ramosetron Hydrochloride Injection | 国药准字H20055174 | 化学药品 | 注射剂 | 8/12/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.